bioAffinity Technologies, Inc.
BIAF
$3.80
-$0.20-5.00%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -3.14M | -5.05M | -4.06M | -2.66M | -2.97M |
| Total Depreciation and Amortization | 123.70K | 113.40K | 113.20K | 154.60K | 153.60K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 66.10K | 2.81M | 1.27M | 326.60K | 234.10K |
| Change in Net Operating Assets | 388.10K | -357.20K | 25.90K | 537.40K | 902.00K |
| Cash from Operations | -2.56M | -2.48M | -2.65M | -1.64M | -1.68M |
| Capital Expenditure | 0.00 | 3.60K | -13.40K | -50.80K | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 0.00 | 3.60K | -13.40K | -50.80K | 0.00 |
| Total Debt Issued | -- | -- | -- | -- | -96.90K |
| Total Debt Repaid | -106.70K | 43.10K | -167.00K | -139.20K | -91.00K |
| Issuance of Common Stock | 1.80M | 9.73M | 3.19M | 1.17M | 2.69M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | 0.00 | 990.00K | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -353.50K | -1.42M | -- | -- | -476.70K |
| Cash from Financing | 1.34M | 9.34M | 3.02M | 1.03M | 2.03M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.22M | 6.87M | 358.10K | -660.60K | 348.70K |